| Generics
for the Europe & Rest of the World markets are commercialized
through collaborations with business partners who are leading Generic
& Innovator Companies.
| USV’s Business model include: |
- Co-development projects wherein we develop
formulations, conduct clinical trials & Bio-equivalence
studies and do Regulatory fillings in collaboration with
our Business partners.
- Technology transfers wherein we provide
complete solutions to our Business partner.
- Out-licensing wherein we license our technology
/ product to our Business partner
- Offering Products Dossiers in CTD formats.
|
Our state-of-the-art manufacturing facilities along
with robust Quality systems and experience in Regulatory filings
and audits bolster this initiative.
|
